Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory
We came across a bearish thesis on Capricor Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research.
Capricor Therapeutics Inc. (CAPR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 1,839,876 | $53,098,821 | +1452% | 0.06% |
| 2. | Suvretta Capital Management Aaron Cowen | 1,785,610 | $51,532,705 | 1.06% | |
| 3. | Tang Capital Management Kevin C. Tang | 1,700,000 | $49,062,000 | 2.42% | |
| 4. | RA Capital Management Peter Kolchinsky | 1,507,844 | $43,516,378 | 0.45% | |
| 5. | Citadel Investment Group Ken Griffin | 901,996 | $26,031,604 | +500% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.36 | 2,798,507 | $14,999,997.52 | 7,090,351 | 2024-09-20 | Filing | |
| $2.75 | 410 | $1,127.50 | 31,536 | 2023-10-12 | Filing | |
| $2.83 | 10,000 | $28,300.00 | 26,856 | 2023-10-10 | Filing | |
| $2.82 | 5,083 | $14,334.06 | 31,126 | 2023-10-09 | Filing | |
| $2.84 | 5,000 | $14,200.00 | 5,000 | 2023-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $64,258.00 | 14,772 | $949,219,176.00 | 0 | 2023-04-17 | Filing | |
| $4.06 | 3,000 | $12,180.00 | 0 | 2023-03-28 | Filing | |
| $3.77 | 28,215 | $106,370.55 | 12,747 | 2022-06-29 | Filing | |
| $4.44 | 17,775 | $78,921.00 | 40,962 | 2022-06-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,850,978 | $82,279,225 | 0% | |
| 2. | 2,561,880 | $73,935,857 | 0% | |
| 3. | 1,432,000 | $41,327,520 | 0% | |
| 4. | 1,179,400 | $34,037,484 | 0% | |
| 5. | 1,017,332 | $29,367,394 | 0% |
News See All
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2025 Earnings Call Transcript
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2025 Earnings Call Transcript November 10, 2025Capricor Therapeutics, Inc. reports earnings inline with expectations.
13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2025 Earnings Call Transcript
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2025 Earnings Call Transcript May 13, 2025Capricor Therapeutics, Inc. misses on earnings expectations.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Second (sic) [Fourth] Quarter 2024 Earnings Call. At this time, all participant lines are in listen-only mode.
10 Worst High-Risk High-Reward Growth Stocks To Buy
On March 14, Tom Lee managing partner and head of research at Fundstrat Global Advisors appeared on a CNBC interview to talk about how the markets react to crises and what approach investors should take...
Capricor Therapeutics, Inc. (CAPR): A Bull Case Theory
We came across a bullish thesis on Capricor Therapeutics, Inc. (CAPR) on wallstreetbets Subreddit Page by androidmj. In this article, we will summarize the bulls’ thesis on CAPR.
10 Best Small-Cap Growth Stocks to Buy Now
On November 4, 2024, Nick Sheridan, Portfolio Manager at Janus Henderson released a report on small-cap stocks exploring how these stocks offer unique growth and diversification opportunities.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Capricor's Third Quarter 2024 Financial Results and Corporate Update Call.
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
Hedge Fund Resource Center